C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Has $204,000 Stock Position in The Cigna Group (NYSE:CI)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors decreased its stake in shares of The Cigna Group (NYSE:CI) by 18.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 738 shares of the health services provider’s stock after selling 172 shares during the quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors’ holdings in The Cigna Group were worth $204,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. International Assets Investment Management LLC increased its holdings in shares of The Cigna Group by 49,287.7% during the 3rd quarter. International Assets Investment Management LLC now owns 400,040 shares of the health services provider’s stock worth $138,590,000 after acquiring an additional 399,230 shares during the last quarter. Swedbank AB increased its holdings in shares of The Cigna Group by 55.1% during the 4th quarter. Swedbank AB now owns 884,406 shares of the health services provider’s stock worth $244,220,000 after acquiring an additional 314,123 shares during the last quarter. FMR LLC increased its holdings in shares of The Cigna Group by 2.0% during the 3rd quarter. FMR LLC now owns 14,230,397 shares of the health services provider’s stock worth $4,929,978,000 after acquiring an additional 279,880 shares during the last quarter. Assenagon Asset Management S.A. increased its holdings in shares of The Cigna Group by 68.4% during the 4th quarter. Assenagon Asset Management S.A. now owns 497,875 shares of the health services provider’s stock worth $137,483,000 after acquiring an additional 202,161 shares during the last quarter. Finally, World Investment Advisors LLC acquired a new position in shares of The Cigna Group during the 3rd quarter worth approximately $69,972,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Stock Performance

NYSE:CI opened at $299.90 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The company has a market cap of $83.42 billion, a price-to-earnings ratio of 24.50, a PEG ratio of 0.97 and a beta of 0.54. The stock has a fifty day moving average price of $285.99 and a 200-day moving average price of $319.78.

The Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the company earned $6.79 EPS. As a group, equities analysts anticipate that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be given a dividend of $1.51 per share. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a dividend yield of 2.01%. The ex-dividend date is Wednesday, March 5th. The Cigna Group’s dividend payout ratio is currently 45.75%.

Wall Street Analyst Weigh In

CI has been the topic of a number of research reports. Raymond James reaffirmed a “strong-buy” rating and issued a $360.00 price objective (down from $415.00) on shares of The Cigna Group in a report on Friday, January 31st. StockNews.com raised The Cigna Group from a “hold” rating to a “buy” rating in a report on Wednesday. Wells Fargo & Company decreased their price objective on The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating on the stock in a report on Tuesday, February 4th. Oppenheimer decreased their price objective on The Cigna Group from $400.00 to $375.00 and set an “outperform” rating on the stock in a report on Friday, January 31st. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $348.00 price objective (down from $394.00) on shares of The Cigna Group in a report on Monday, February 3rd. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, The Cigna Group currently has an average rating of “Buy” and an average target price of $373.69.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.